In situ and in vitro study of colocalization and segregation of α-synuclein, ubiquitin, and lipids in Lewy bodies

被引:224
作者
Gai, WP [1 ]
Yuan, HX
Li, XQ
Power, JTH
Blumbergs, PC
Jensen, PH
机构
[1] Flinders Univ S Australia, Dept Physiol, Bedford Pk, SA 5042, Australia
[2] Flinders Univ S Australia, Ctr Neurosci, Bedford Pk, SA 5042, Australia
[3] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia
[4] Inst Med & Vet Sci, Dept Neuropathol, Adelaide, SA, Australia
[5] Univ Aarhus, Dept Med Biochem, Aarhus, Denmark
基金
英国医学研究理事会;
关键词
alpha-synuclein; ubiquitin; lipid; Lewy body; Parkinson's disease; dementia with Lewy bodies;
D O I
10.1006/exnr.2000.7527
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
alpha -Synuclein and ubiquitin are two Lewy body protein components that may play antagonistic roles in the pathogenesis of Lewy bodies. We examined the relationship between alpha -synuclein, ubiquitin, and lipids in Lewy bodies of fixed brain sections or isolated from cortical tissues of dementia with Lewy bodies. Lewy bodies exhibited a range of labeling patterns for alpha -synuclein and ubiquitin, from a homogeneous pattern in which alpha -synuclein and ubiquitin were evenly distributed and overlapped across the inclusion body to a concentric pattern in which alpha -synuclein and ubiquitin were partially segregated, with alpha -synuclein labeling concentrated in the peripheral domain and ubiquitin in the central domain of the Lewy body. Lipids represented a significant component in both homogeneous and concentric Lewy bodies. These results suggest that Lewy bodies are heterogeneous in their subregional composition. The segregation of alpha -synuclein to Lewy body peripheral domain is consistent with the hypothesis that alpha -synuclein is continually deposited onto Lewy bodies. (C) 2000 Academic Press.
引用
收藏
页码:324 / 333
页数:10
相关论文
共 46 条
  • [1] Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system
    Abeliovich, A
    Schmitz, Y
    Fariñas, I
    Choi-Lundberg, D
    Ho, WH
    Castillo, PE
    Shinsky, N
    Verdugo, JMG
    Armanini, M
    Ryan, A
    Hynes, M
    Phillips, H
    Sulzer, D
    Rosenthal, A
    [J]. NEURON, 2000, 25 (01) : 239 - 252
  • [2] NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy
    Arima, K
    Uéda, K
    Sunohara, N
    Arakawa, K
    Hirai, S
    Nakamura, M
    Tonozuka-Uehara, H
    Kawai, M
    [J]. ACTA NEUROPATHOLOGICA, 1998, 96 (05) : 439 - 444
  • [3] Baba M, 1998, AM J PATHOL, V152, P879
  • [4] Degradation of α-synuclein by proteasome
    Bennett, MC
    Bishop, JF
    Leng, Y
    Chock, PB
    Chase, TN
    Mouradian, MM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) : 33855 - 33858
  • [5] THE INCIDENCE AND CHARACTERISTICS OF LEWY BODIES IN IDIOPATHIC PARALYSIS AGITANS (PARKINSONS DISEASE)
    BETHLEM, J
    JAGER, WAD
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) : 74 - 80
  • [6] Extensive axonal Lewy neurites in Parkinson's disease:: a novel pathological feature revealed by α-synuclein immunocytochemistry
    Braak, H
    Sandmann-Keil, D
    Gai, WP
    Braak, E
    [J]. NEUROSCIENCE LETTERS, 1999, 265 (01) : 67 - 69
  • [7] NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES
    BRAAK, H
    BRAAK, E
    [J]. ACTA NEUROPATHOLOGICA, 1991, 82 (04) : 239 - 259
  • [8] Buée L, 1999, BRAIN PATHOL, V9, P681
  • [9] THE UBIQUITIN-MEDIATED PROTEOLYTIC PATHWAY
    CIECHANOVER, A
    [J]. BRAIN PATHOLOGY, 1993, 3 (01) : 67 - 75
  • [10] Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease
    Conway, KA
    Harper, JD
    Lansbury, PT
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1318 - 1320